Does MEPOLIZUMAB Cause Upper respiratory tract infection? 555 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 555 reports of Upper respiratory tract infection have been filed in association with MEPOLIZUMAB (Nucala). This represents 1.3% of all adverse event reports for MEPOLIZUMAB.
555
Reports of Upper respiratory tract infection with MEPOLIZUMAB
1.3%
of all MEPOLIZUMAB reports
34
Deaths
300
Hospitalizations
How Dangerous Is Upper respiratory tract infection From MEPOLIZUMAB?
Of the 555 reports, 34 (6.1%) resulted in death, 300 (54.1%) required hospitalization, and 41 (7.4%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 555 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which MEPOLIZUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE